Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappaB signaling
- PMID: 16707445
- DOI: 10.1158/0008-5472.CAN-05-4158
Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappaB signaling
Abstract
Previous studies addressing functional aspects of nuclear factor kappaB (NF-kappaB) activation in normal and transformed keratinocytes revealed complex and seemingly contradictory roles of this transcription factor in this cell type. In normal skin, NF-kappaB signaling seems to inhibit squamous cell carcinoma development whereas, in squamous cell carcinoma themselves, deregulated NF-kappaB expression and/or signaling is frequently observed. To further investigate this paradox, we focused on NF-kappaB activation as it relates to the transformed phenotype of immortalized but nontumorigenic human keratinocytes (HaCaT cells). We observed that NF-kappaB activity contributed to survival and growth of cultured HaCaT keratinocytes as shown by use of pharmacologic NF-kappaB inhibitors, RNA interference, and inducible overexpression of a dominant interfering IkappaB construct. NF-kappaB activation was largely provided through interaction with extracellular matrix components because preventing cell attachment by forced suspension culture markedly reduced NFkappaB signaling associated with cell death (anoikis); conversely, anoikis was partially reversed by NF-kappaB activation induced either by tumor necrosis factor-alpha treatment or by overexpressing the NF-kappaB p65 subunit in HaCaT cells. Furthermore, overexpression of NF-kappaBp65 in HaCaT cells induced colony formation in soft agar and tumorigenicity in nude mice. In summary, as opposed to normal keratinocytes, immortalized HaCaT keratinocytes provide a cellular context in which deregulated NF-kappaB signaling supports multiple malignant traits in vitro and in vivo.
Similar articles
-
Enforced expression of nuclear factor kappa B in p53 deficient keratinocytes induces cell cycle, angiogenic potential and tumorigenesis.Oral Oncol. 2012 Apr;48(4):303-10. doi: 10.1016/j.oraloncology.2011.11.008. Epub 2011 Dec 3. Oral Oncol. 2012. PMID: 22143006
-
Aberrant NF-kappaB activity in HaCaT cells alters their response to UVB signaling.J Invest Dermatol. 2006 Aug;126(8):1885-92. doi: 10.1038/sj.jid.5700333. Epub 2006 Jun 1. J Invest Dermatol. 2006. PMID: 16741515
-
Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides.J Invest Dermatol. 2002 Dec;119(6):1244-53. doi: 10.1046/j.1523-1747.2002.19602.x. J Invest Dermatol. 2002. PMID: 12485424
-
Novel initiation genes in squamous cell carcinomagenesis: a role for substrate-specific ubiquitylation in the control of cell survival.Mol Carcinog. 2007 Aug;46(8):585-90. doi: 10.1002/mc.20344. Mol Carcinog. 2007. PMID: 17626251 Review.
-
Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes.Mol Carcinog. 1998 Nov;23(3):144-58. doi: 10.1002/(sici)1098-2744(199811)23:3<144::aid-mc3>3.0.co;2-u. Mol Carcinog. 1998. PMID: 9833775 Review.
Cited by
-
PKK suppresses tumor growth and is decreased in squamous cell carcinoma of the skin.J Invest Dermatol. 2015 Mar;135(3):869-876. doi: 10.1038/jid.2014.428. Epub 2014 Oct 6. J Invest Dermatol. 2015. PMID: 25285922 Free PMC article.
-
Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma.BMC Genomics. 2012 May 1;13:160. doi: 10.1186/1471-2164-13-160. BMC Genomics. 2012. PMID: 22549044 Free PMC article.
-
Spatial proteomics reveals subcellular reorganization in human keratinocytes exposed to UVA light.iScience. 2022 Mar 16;25(4):104093. doi: 10.1016/j.isci.2022.104093. eCollection 2022 Apr 15. iScience. 2022. PMID: 35372811 Free PMC article.
-
The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy.Oncotarget. 2017 May 25;8(34):57813-57825. doi: 10.18632/oncotarget.18175. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915713 Free PMC article. Review.
-
A single dose of Ultraviolet-A induces proteome remodeling and senescence in primary human keratinocytes.Sci Rep. 2021 Dec 2;11(1):23355. doi: 10.1038/s41598-021-02658-5. Sci Rep. 2021. PMID: 34857819 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources